Go to Top
X

Media Room

AEON Clinical Laboratory Partners with Authentidate’s HIPAA – Compliant Telehealth Platform for Houston Clinics

Initial implementation of our telehealth-based mental health and rehab treatment in 8 clinics, which serve 80,000 patients annually

Sunday, October 4, 2015
BERKELEY HEIGHTS, N.J. and GAINESVILLE, GA

Authentidate Holding Corp. (ADAT), a provider of secure web-based revenue cycle management applications and telehealth products and services for healthcare organizations, today announced the first cross-sold application of Authentidate’s leading telehealth solutions and AEON Clinical Laboratory’s leading clinical solutions. As announced on August 25, 2015, Authentidate and AEON Clinical Laboratories have entered into a non-binding letter of intent to combine.

Authentidate will provide its HIPAA-compliant telehealth platform to AEON Clinical Laboratory, an expanding clinical laboratory. The initial implementation will be rolled out to eight Houston-area clinics, with upwards of 80,000 patients, to deliver remote mental health and rehab treatment. The program is ultimately expected to be expanded to 160 clinics. Outpatient reimbursement averages from $6,000-$8,000 per patient, per month. With the first eight clinics, AEON expects to treat 10,000 patients annually, and treatment duration to be one month.

AEON Clinical Laboratory’s sister company, Palms Recovery, which owns inpatient and outpatient treatment companies with clinicians will provide treatment utilizing video chat from the clinician’s computer and using Authentidate’s Web-based telehealth application.

Richard Hersperger, CEO of AEON Clinical Laboratories commented, “This is exactly the type of synergy we expected when we first approached Authentidate. The combination of Authentidate’s telehealth platform, and our sister company, Palms Recovery, will provide mental health services to patients of Houston Clinics who otherwise would not be able to get treated for mental health and drug and alcohol rehabilitative services. It’s exciting to be rolling out to an initial eight clinics and we look forward to expanding to all 160 clinics.”

Ian Bonnet, President and CEO of Authentidate, noted “Authentidate’s telehealth solutions are extraordinary tools for patient care. We are thrilled that our solutions will enable AEON and Palms Recovery to have a progressive impact on patient lives at Houston Clinics.

Doctor Mustafa Chagani of V Care, of Houston Clinics remarked, “We are excited to be using cutting edge technology to deliver care to our patients so that we can achieve improved outcomes and reduce our costs of providing care. Over a course of seven to 20 days, for three to eight hours per day, we will be able to offer members of our community access to mental health services for substance and alcohol recovery either one-on-one or in a group setting, for the very first time. Houston Clinics are grateful that AEON Clinical Laboratories, partnering with Authentidate’s technology, will enable us to introduce a much needed service to our patients.”

About Houston Clinics

Houston Clinics Houston Clinics provides uninsured and under insured Texan families with affordable, comprehensive and compassionate access to medical and dental care with same day service. Medical services available include consultation, treatment, diagnostic and imaging services, preventative programs, specialty care and day surgery referrals. The vision of Houston Clinics is equal and fair health care access for all, regardless of the ability to pay. To learn more, please visit http://www.vcareclinics.org

About AEON Clinical Laboratories
AEON Clinical Laboratories is a growing comprehensive and efficient clinical laboratory using state of the art testing equipment. Housed in a 28,000 square foot campus, in Gainesville, Georgia, AEON emphasizes Technology Innovation. AEON has developed proprietary methodologies that provide some of the fastest and most reliable urine and oral fluid (saliva) test results in the nation. AEON provides health care professionals with four primary tests: Medical Toxicology, Pharmacogenomics, Cancer Genetic Testing, and Molecular Biology.

About Authentidate Holding Corp.
Authentidate Holding Corp. is a provider of web-based revenue cycle management applications and telehealth products and services that enable healthcare organizations to coordinate care for patients and enhance related administrative and clinical workflows. Authentidate’s products and services enable healthcare organizations to increase revenues, reduce costs and enhance patient care by eliminating paper and manual work steps from clinical and administrative processes. Authentidate’s telehealth solutions combine patient vital signs monitoring with a web application that streamlines patient care management. Delivered as Software as a Service (SaaS), customers only require an Internet connection and web browser to access our web-based applications thereby utilizing previous investments in systems and technology. The company’s healthcare customers and users include leading homecare companies, health systems, and physician groups. These organizations utilize the company’s products and services to coordinate care for patients outside of acute care.

For more information, visit www.authentidate.com

This press release contains forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and section 21E of the Securities Act of 1934. When used in this release, the words “believe,” “anticipate,” “think,” “intend,” “plan,” “will be,” “expect,” and similar expressions identify such forward-looking statements. Such statements regarding future events and/or the future financial performance of the company are subject to certain risks and uncertainties, which could cause actual events or the actual future results of the company to differ materially from any forward-looking statement. Such risks and uncertainties include, among other things, the availability of any needed financing, the company’s ability to implement its business plan for various applications of its technologies, the impact of competition, the management of growth, and the other risks and uncertainties that may be detailed from time to time in the company’s reports filed with the Securities and Exchange Commission. In light of the significant risks and uncertainties inherent in the forward-looking statements included herein, the inclusion of such statements should not be regarded as a representation by the company or any other person that the objectives and plans of the company will be achieved.
Authentidate, Inscrybe and InscrybeMD are registered trademarks of Authentidate Holding Corp. All other trade names are the property of their respective owners.